Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility

Pfizer confirms all its colleagues are safe following a tornado that damaged predominantly the warehouse portion of its manufacturing facility in Rocky M...

July 24, 2023 | Monday | News
Tillotts Pharma and TVM Capital Form Mage Biologics to Develop Oral Antibody Therapy for Ulcerative Colitis

Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to ensure optimal and local trea...

July 21, 2023 | Friday | News
Gilead Announces $8 Million in Grant Funding for Viral Hepatitis Relink Program in the U.S.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $8 million in funding through a new grant program in the United States call...

July 21, 2023 | Friday | News
Massive Bio and CureMatch Partner to Revolutionize Cancer Treatment with AI and Clinical Trial Accessibility.

Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representa...

July 19, 2023 | Wednesday | News
HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia&...

July 19, 2023 | Wednesday | News
DTx Pharma announces acquisition by Novartis

DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON™) platform facilitates extra-hepatic delivery of siRNA therapeutics Acquisition ...

July 18, 2023 | Tuesday | News
Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

 Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) r...

July 18, 2023 | Tuesday | News
Karyopharm Receives FDA Fast Track Designation for Selinexor for the Treatment of Myelofibrosis

Regulatory Designation Includes Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis and Post-Polycythemia Vera Myelofibrosis – &ndas...

July 18, 2023 | Tuesday | Regulatory
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Modi Ventures Launches $32M Fund to Disrupt Health and Medicine Tech

Modi Ventures, a newly launched venture partnership investing in fund managers and founders building companies shaping the future of humanity, today announ...

July 17, 2023 | Monday | News
Lilly Acquires Versanis to Enhance Cardiometabolic Disease Care

Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab...

July 17, 2023 | Monday | News
GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in p...

July 14, 2023 | Friday | News
InnoCare and ArriVent Announce Clinical Development Collaboration

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases and ArriVent Bi...

July 14, 2023 | Friday | News
Inizio Engage launches Patient Access Services

 Inizio Engage is pleased to announce the launch of Patient Access Services. This custom-built, integrated suite of patient support ser...

July 13, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close